PHRESH: Physiological Demands Related to Exercises in Singing for Lung Health

Sponsor
Imperial College London (Other)
Overall Status
Terminated
CT.gov ID
NCT04121351
Collaborator
(none)
8
1
18.7
0.4

Study Details

Study Description

Brief Summary

This study will assess the physiological demands related to Singing for Lung Health participation.

Condition or Disease Intervention/Treatment Phase
  • Other: Singing participation

Detailed Description

This study will assess the physiological demands experienced by healthy volunteers participating in components of a Singing for Lung Health session. Oxygen consumption, heart rate, and fixed body sensor output puts related to balance and movement intensity will be assessed. The same parameters will also be assessed during walking on a treadmill at different speeds for comparison.

Study Design

Study Type:
Observational
Actual Enrollment :
8 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Official Title:
Physiological Demands Related to Exercises in Singing for Lung Health: A Pilot Study (PHRESH Study)
Actual Study Start Date :
Oct 1, 2019
Actual Primary Completion Date :
Apr 23, 2021
Actual Study Completion Date :
Apr 23, 2021

Outcome Measures

Primary Outcome Measures

  1. Oxygen consumption in mL per kilogram per minute during different components of Singing for Lung Health(physical warm up, rhythm exercises, pitch exercises, vocal exercises, repertoire and relaxation) [Single assessment at baseline.]

    Assessed using portable metabolic measurement equipment (Oxycon Mobile made by Vyaire).

Secondary Outcome Measures

  1. Heart rate during different components of Singing for Lung Health (physical warm up, rhythm exercises, pitch exercises, vocal exercises, repertoire and relaxation). [Single assessment at baseline.]

    Assessed using a portable heart rate monitor.

  2. Comparison of oxygen consumption, in mL per kilogram per minute, achieved during each component of Singing for Lung Health with walking at different speeds [Single assessment at baseline.]

    Oxygen consumption, in mL per kilogram per minute, will be assessed during different components of Singing for Lung Health(physical warm up, rhythm exercises, pitch exercises, vocal exercises, repertoire and relaxation. This will be compared with oxygen consumption while walking at three speeds on a treadmill (slow, medium and brisk). Oxygen consumption will be assessed using portable metabolic measurement equipment (Oxycon Mobile made by Vyaire).

  3. Movement intensity during different components of Singing for Lung Health(physical warm up, rhythm exercises, pitch exercises, vocal exercises, repertoire and relaxation). [Single assessment at baseline.]

    Assessed with the McRoberts fixed-body sensor MoveTest device.

  4. Changes in centre of mass during different components of Singing for Lung Health (physical warm up, rhythm exercises, pitch exercises, vocal exercises, repertoire and relaxation). [Single assessment at baseline]

    Assessed with the McRoberts fixed-body sensor MoveTest device.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy adult

  • Able to undertake singing components

  • Able to undertake walking test

  • No contraindications to exercise

  • No contraindications to spirometry as per American Thoracic Society/European Respiratory Society criteria

  • Capacity to consent to exercise testing.

Exclusion Criteria:
  • Any health condition that would preclude them from singing or impede physical activity

  • Inability to comply or follow singing exercise instructions

  • Active musculoskeletal disease impairing exercise.

Contacts and Locations

Locations

Site City State Country Postal Code
1 National Heart and Lung Institute, Imperial College London London United Kingdom SW3 6NP

Sponsors and Collaborators

  • Imperial College London

Investigators

  • Principal Investigator: Keir Philip, Imperial College London

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Imperial College London
ClinicalTrials.gov Identifier:
NCT04121351
Other Study ID Numbers:
  • ICREC ref:19IC5429
First Posted:
Oct 9, 2019
Last Update Posted:
Apr 28, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Imperial College London

Study Results

No Results Posted as of Apr 28, 2021